Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
FirstTeam® connects its entire technology ecosystem with Purlin's AI-powered operating model for real estate
-
Momentum Environmental Announces Acquisition of Corbett Industrial Cleaning Services
-
Circle Acquires IBM Blockchain Patent Portfolio
-
Cadiz Inc. Announces CFO Succession
-
Seven Hills Realty Trust Closes $24.3 Million First Mortgage Loan to Refinance a Retail Property in Park City, Utah
-
SpotOn Highlights Q2 2026 Momentum with Proactive AI and Faster Access to Cash
-
Wayne County Selects e2Companies for New York Microgrid and Energy Resiliency Project
-
Varex Schedules Third Quarter Fiscal Year 2026 Earnings Release and Conference Call
-
Ode with Anthropic and LogicGate Announce Partnership to Scale Expert-Led Client Outcomes through Accelerated Agentic Capabilities
-
NICE Actimize Positioned as a Luminary in Celent’s 2026 “Know Your Customer Systems: Adverse Media Screening” Report
-
49th Parallel Wealth Management Launches a Free OAS Clawback Calculator -- Anchoring a New Suite of Cross-Border Planning Tools
-
Falco Files Updated Feasibility Study for Its Horne 5 Project
-
AtriCure to Participate at Upcoming Investor Conferences
-
LMU MAKES TENNESSEE HISTORY WITH THE STATE'S FIRST 90-CREDIT-HOUR BACHELOR'S DEGREE
-
UBS Hires Financial Advisor Team of Four in Tampa, FL
-
Novanta Completes Acquisition of Riverpoint Medical
-
Green Dot Named a Leader in Earned Wage Access by Everest Group
-
Spruce Biosciences Appoints Adrian Quartel, M.D., FFPM, as Chief Medical Officer
-
Otsuka to Present Pivotal Two-Year eGFR Results from the Phase 3 VISIONARY Trial of VOYXACT® (sibeprenlimab-szsi) in IgA Nephropathy (IgAN) at GlomCon Hawaii 2026
-
Cotality Certified as a Great Place to Work Certification for Third Consecutive Year
-
Insilico Medicine Announces Oral Presentation at ESMO 2026 for Phase 1 Clinical Study of ISM6331 in Mesothelioma and Advanced Solid Tumors
-
Stellar Cyber Names Brite, Inspira and M-Theory as First Infinity Delivery Partners
-
Frost & Sullivan Selects Fusemachines as a Strategic Partner for Agentic AI
-
Altus Announces CFO Transition
-
Genius Group Offers Share Loyalty Bonus Program Delivering up to 59% Return on Investment in six months, Closing July 31, 2026.
-
Linkage Global Unveils "Human Resonance OS," Advancing Its AI-Enabled Wellness Ecosystem as Next-Generation Healthcare Infrastructure
-
Rezolve Ai Delivers Breakout First-Half Performance: Preliminary H1 2026 Revenue Expected to Reach Approximately $127 Million, Nearly 20x H1 2025
-
EagleNXT Joint Venture “ThirdEye USA” Selected to Participate in EXTiC 26-2 Counter-UAS Experimentation Event
-
Curium, in collaboration with nuclear cardiology leaders, announces immediate return of Thallous Chloride TI 201 Injection in the U.S. to support high-stakes cardiac imaging needs
-
CALIFORNIA BANCORP REPORTS STRONG SECOND QUARTER EARNINGS, SIGNIFICANT LOAN GROWTH AND IMPROVED CREDIT QUALITY
-
GCL Schedules Fiscal Year 2026 Earnings Release and Conference Call Date
-
NANO Nuclear Energy Selected by AFWERX for SBIR Phase I Award to Advance KRONOS MMR™ for the U.S. Air Force
-
NAVER, NVIDIA and Brookfield to Expand Korea’s National AI Factory Infrastructure Buildout
-
FLYTE Partners with 319 Golf Society and Named Exclusive Private Aviation Partner
-
Swarmer and Brightline Partner on AI Data Collection and Drone Interoperability for U.S. Department of War
-
Teads to Release Second Quarter 2026 Financial Results on August 6, 2026
-
Amaze Announces Full Compliance with NYSE American Continued Listing Standards and Resumption of Trading
-
Shimmick Secures More Than $265 Million in Water, Transportation and Energy Infrastructure Awards
-
Mount Logan Capital Inc. Announces Receipt of AM Best Rating for Ability Insurance Company
-
Waterco Modernizes B2B Ordering with BigCommerce, Improving Ordering and Buying Efficiency Across 45,000 Products
-
Calidi Biotherapeutics Presents New Data on Cytotoxicity and IL-15 SA Expression in Human and Murine Tumor Cells at the American Association for Cancer Research Drug Discovery and Development Confere
-
BlackLine Advances Governed AI for Finance with General Availability of Verity™ Prepare
-
Kaltura Delivers Record-Scale Live Streaming for the 2026 FIFA World Cup, Previews Agentic Avatar Experiences for Live Sports
-
FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.
-
InoBat and Cartesian Growth Corporation II Announce Business Combination Agreement to Accelerate Expansion of Battery Energy Storage Systems
-
Sharplink to Host Second Quarter 2026 Earnings Conference Call and Webcast on August 10, 2026 at 8:30 A.M. E.T.
-
Pacira BioSciences Advances PCRX-201 Development Program with Successful Transition to Scalable Commercial Manufacturing Process
-
Kyverna Therapeutics and ElevateBio Enter into Commercial Manufacturing and Supply Agreement for Miv-cel
-
DeFi Development Corp. to Announce Second Quarter 2026 Financial Results
-
Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing
